| Year |
Citation |
Score |
| 2023 |
Bush K. Classification for β-Lactamases: Historical Perspectives. Expert Review of Anti-Infective Therapy. PMID 36951174 DOI: 10.1080/14787210.2023.2194633 |
0.301 |
|
| 2022 |
Zhang Q, Neidig N, Chu TY, Divoky C, Carpenter J, Lee-Hsiao C, Threatt H, Sultana R, Bush K. In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates. Diagnostic Microbiology and Infectious Disease. 103: 115651. PMID 35228130 DOI: 10.1016/j.diagmicrobio.2022.115651 |
0.378 |
|
| 2021 |
Das S, Bush K. Success and Challenges Associated with Large Scale Collaborative Surveillance for Carbapenemase Genes in Gram Negative Bacteria. Antimicrobial Agents and Chemotherapy. aac0229921. PMID 34930024 DOI: 10.1128/aac.02299-21 |
0.302 |
|
| 2020 |
Theuretzbacher U, Bush K, Harbarth S, Paul M, Rex JH, Tacconelli E, Thwaites GE. Critical analysis of antibacterial agents in clinical development. Nature Reviews. Microbiology. PMID 32152509 DOI: 10.1038/S41579-020-0340-0 |
0.446 |
|
| 2020 |
Bush K, Bradford PA. Epidemiology of β-Lactamase-Producing Pathogens. Clinical Microbiology Reviews. 33. PMID 32102899 DOI: 10.1128/Cmr.00047-19 |
0.423 |
|
| 2019 |
Carpenter J, Neidig N, Campbell A, Thornsberry T, Truex T, Fortney T, Zhang Y, Bush K. Activity of imipenem/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance. The Journal of Antimicrobial Chemotherapy. PMID 31430370 DOI: 10.1093/Jac/Dkz354 |
0.464 |
|
| 2019 |
Bush K, Bradford PA. Publisher Correction: Interplay between β-lactamases and new β-lactamase inhibitors. Nature Reviews. Microbiology. PMID 31040389 DOI: 10.1038/S41579-019-0206-5 |
0.312 |
|
| 2019 |
Bush K, Bradford PA. Interplay between β-lactamases and new β-lactamase inhibitors. Nature Reviews. Microbiology. PMID 30837684 DOI: 10.1038/S41579-019-0159-8 |
0.429 |
|
| 2018 |
Bush K. Past and Present Perspectives on β-Lactamases. Antimicrobial Agents and Chemotherapy. PMID 30061284 DOI: 10.1128/Aac.01076-18 |
0.442 |
|
| 2018 |
Hemarajata P, Amick T, Yang S, Gregson A, Holzmeyer C, Bush K, Humphries RM. Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy. The Journal of Antimicrobial Chemotherapy. 73: 1256-1262. PMID 29471486 DOI: 10.1093/Jac/Dky028 |
0.438 |
|
| 2018 |
Bush K. Game Changers: New β-Lactamase Inhibitor Combinations Targeting Antibiotic Resistance in Gram-Negative Bacteria. Acs Infectious Diseases. 4: 84-87. PMID 29232103 DOI: 10.1021/Acsinfecdis.7B00243 |
0.494 |
|
| 2018 |
Yang S, Hemarajata P, Shevy L, Maciariello M, Culbreath K, Bush K, Humphries R. Unusual carbapenem resistant but ceftriaxone and cefepime susceptible isolated from a blood culture: Case report and whole-genome sequencing investigation. Idcases. 11: 9-11. PMID 29204354 DOI: 10.1016/J.Idcr.2017.11.007 |
0.37 |
|
| 2017 |
Zhang Y, Kashikar A, Bush K. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE). The Journal of Antimicrobial Chemotherapy. 72: 2792-2795. PMID 29091224 DOI: 10.1093/Jac/Dkx261 |
0.426 |
|
| 2017 |
Zhang Y, Kashikar A, Brown CA, Denys G, Bush K. Unusual Escherichia coli PBP 3 Insertion Sequence Identified from a Collection of Carbapenem-Resistant Enterobacteriaceae Tested with a Combination of Ceftazidime-, Ceftaroline-, or Aztreonam-Avibactam. Antimicrobial Agents and Chemotherapy. 61. PMID 28559260 DOI: 10.1128/Aac.00389-17 |
0.406 |
|
| 2017 |
Bush K, Page MGP. What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles. Journal of Pharmacokinetics and Pharmacodynamics. 44: 113-132. PMID 28161807 DOI: 10.1007/S10928-017-9506-4 |
0.443 |
|
| 2016 |
Kao C, Lin X, Yi G, Zhang Y, Rowe-Magnus DA, Bush K. Cathelicidin Antimicrobial Peptides with Reduced Activation of Toll-Like Receptor Signaling Have Potent Bactericidal Activity against Colistin-Resistant Bacteria. Mbio. 7. PMID 27651360 DOI: 10.1128/Mbio.01418-16 |
0.343 |
|
| 2016 |
Zhang Y, Lin X, Bush K. In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline. The Journal of Antibiotics. 69: 600-4. PMID 27353166 DOI: 10.1038/Ja.2016.73 |
0.492 |
|
| 2016 |
Bush K, Bradford PA. β-Lactams and β-Lactamase Inhibitors: An Overview. Cold Spring Harbor Perspectives in Medicine. 6. PMID 27329032 DOI: 10.1101/Cshperspect.A025247 |
0.435 |
|
| 2016 |
Jacoby GA, Bonomo RA, Bradford PA, Bush K, Doi Y, Feldgarden M, Haft D, Klimke W, Nordmann P, Palzkill T, Poirel L, Prasad A, Rossolini GM, Walsh T. Comment on: Resistance gene naming and numbering: is it a new gene or not? The Journal of Antimicrobial Chemotherapy. 71: 2677-8. PMID 27261266 DOI: 10.1093/Jac/Dkw204 |
0.306 |
|
| 2016 |
Bush K. Overcoming β-lactam resistance in Gram-negative pathogens. Future Medicinal Chemistry. 8: 921-4. PMID 27228233 DOI: 10.4155/Fmc-2016-0076 |
0.448 |
|
| 2015 |
Bush K. Investigational Agents for the Treatment of Gram-Negative Bacterial Infections: A Reality Check. Acs Infectious Diseases. 1: 509-11. PMID 27623407 DOI: 10.1021/Acsinfecdis.5B00100 |
0.453 |
|
| 2015 |
Bush K. A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens. International Journal of Antimicrobial Agents. 46: 483-93. PMID 26498989 DOI: 10.1016/J.Ijantimicag.2015.08.011 |
0.474 |
|
| 2015 |
Bush K. Antibiotics: Synergistic MRSA combinations. Nature Chemical Biology. 11: 832-3. PMID 26485079 DOI: 10.1038/Nchembio.1935 |
0.42 |
|
| 2015 |
Li H, Estabrook M, Jacoby GA, Nichols WW, Testa RT, Bush K. In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations. Antimicrobial Agents and Chemotherapy. 59: 1789-93. PMID 25534728 DOI: 10.1128/Aac.04191-14 |
0.419 |
|
| 2014 |
Grant EB, Foleno BD, Goldschmidt R, Hilliard JJ, Lin SC, Morrow B, Paget SD, Weidner-Wells MA, Xu X, Xu X, Murray WV, Bush K, Macielag MJ. 7-(4-Alkylidenylpiperidinyl)-quinolone bacterial topoisomerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 5502-6. PMID 25455493 DOI: 10.1016/j.bmcl.2014.10.014 |
0.318 |
|
| 2014 |
Page MG, Bush K. Discovery and development of new antibacterial agents targeting Gram-negative bacteria in the era of pandrug resistance: is the future promising? Current Opinion in Pharmacology. 18: 91-7. PMID 25277839 DOI: 10.1016/J.Coph.2014.09.008 |
0.457 |
|
| 2014 |
Estabrook M, Bussell B, Clugston SL, Bush K. In vitro activity of ceftolozane-tazobactam as determined by broth dilution and agar diffusion assays against recent U.S. Escherichia coli isolates from 2010 to 2011 carrying CTX-M-type extended-spectrum β-lactamases. Journal of Clinical Microbiology. 52: 4049-52. PMID 25143578 DOI: 10.1128/Jcm.02357-14 |
0.352 |
|
| 2014 |
Perez F, Arias CA, Bush K, Drusano GL, Lolans K, Munoz-Price LS, Nicolau DP, Queenan AM, Rice LB, Segreti J, Shlaes DM, Weinstein RA, Bonomo RA. In memoriam: John P. Quinn, MD. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 748-50. PMID 24336826 DOI: 10.1093/Cid/Cit801 |
0.442 |
|
| 2014 |
Pucci MJ, Page MGP, Bush K. Cautious optimism for the antibacterial pipeline: Despite dire warnings, there is resurgent effort to develop novel antibiotics, with several dozen candidate drugs already entered into clinical trials Microbe. 9: 147-152. DOI: 10.1128/Microbe.9.147.1 |
0.388 |
|
| 2013 |
Bush K. Carbapenemases: Partners in crime. Journal of Global Antimicrobial Resistance. 1: 7-16. PMID 27873609 DOI: 10.1016/J.Jgar.2013.01.005 |
0.487 |
|
| 2013 |
Pucci MJ, Bush K. Investigational antimicrobial agents of 2013. Clinical Microbiology Reviews. 26: 792-821. PMID 24092856 DOI: 10.1128/Cmr.00033-13 |
0.422 |
|
| 2013 |
Bush K. The ABCD's of β-lactamase nomenclature. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy. 19: 549-59. PMID 23828655 DOI: 10.1007/S10156-013-0640-7 |
0.388 |
|
| 2013 |
Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, ... ... Bush K, et al. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center. Antimicrobial Agents and Chemotherapy. 57: 4010-8. PMID 23752516 DOI: 10.1128/Aac.02516-12 |
0.308 |
|
| 2013 |
Bush K. Introduction to Antimicrobial Therapeutics Reviews: the bacterial cell wall as an antimicrobial target. Annals of the New York Academy of Sciences. 1277: v-vii. PMID 23346862 DOI: 10.1111/Nyas.12025 |
0.312 |
|
| 2013 |
Bush K. Proliferation and significance of clinically relevant β-lactamases. Annals of the New York Academy of Sciences. 1277: 84-90. PMID 23346859 DOI: 10.1111/Nyas.12023 |
0.453 |
|
| 2013 |
Bush K, Pannell M, Lock JL, Queenan AM, Jorgensen JH, Lee RM, Lewis JS, Jarrett D. Detection systems for carbapenemase gene identification should include the SME serine carbapenemase. International Journal of Antimicrobial Agents. 41: 1-4. PMID 23219246 DOI: 10.1016/J.Ijantimicag.2012.08.008 |
0.441 |
|
| 2012 |
Bush K. Antimicrobial agents targeting bacterial cell walls and cell membranes. Revue Scientifique Et Technique (International Office of Epizootics). 31: 43-56. PMID 22849267 |
0.319 |
|
| 2012 |
Bush K. Improving known classes of antibiotics: an optimistic approach for the future. Current Opinion in Pharmacology. 12: 527-34. PMID 22748801 DOI: 10.1016/J.Coph.2012.06.003 |
0.45 |
|
| 2012 |
Pulcini C, Bush K, Craig WA, Frimodt-Møller N, Grayson ML, Mouton JW, Turnidge J, Harbarth S, Gyssens IC. Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 268-74. PMID 22198992 DOI: 10.1093/Cid/Cir838 |
0.421 |
|
| 2011 |
Bush K. Introduction to Antimicrobial Therapeutics Reviews: antibiotics that target the ribosome. Annals of the New York Academy of Sciences. 1241: vii-ix. PMID 22191533 DOI: 10.1111/J.1749-6632.2011.06367.X |
0.324 |
|
| 2011 |
Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, et al. Tackling antibiotic resistance. Nature Reviews. Microbiology. 9: 894-6. PMID 22048738 DOI: 10.1038/Nrmicro2693 |
0.413 |
|
| 2011 |
Bush K, Pucci MJ. New antimicrobial agents on the horizon. Biochemical Pharmacology. 82: 1528-39. PMID 21798250 DOI: 10.1016/J.Bcp.2011.07.077 |
0.427 |
|
| 2011 |
Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. Annual Review of Microbiology. 65: 455-78. PMID 21740228 DOI: 10.1146/Annurev-Micro-090110-102911 |
0.446 |
|
| 2010 |
Bush K. The coming of age of antibiotics: discovery and therapeutic value. Annals of the New York Academy of Sciences. 1213: 1-4. PMID 21175674 DOI: 10.1111/J.1749-6632.2010.05872.X |
0.359 |
|
| 2010 |
Bush K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Current Opinion in Microbiology. 13: 558-64. PMID 20920882 DOI: 10.1016/J.Mib.2010.09.006 |
0.459 |
|
| 2010 |
Bush K, Macielag MJ. New β-lactam antibiotics and β-lactamase inhibitors. Expert Opinion On Therapeutic Patents. 20: 1277-93. PMID 20839927 DOI: 10.1517/13543776.2010.515588 |
0.455 |
|
| 2010 |
Bush K. Bench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections. Critical Care (London, England). 14: 224. PMID 20594363 DOI: 10.1186/Cc8892 |
0.506 |
|
| 2010 |
Amsler K, Santoro C, Foleno B, Bush K, Flamm R. Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against gram-negative and gram-positive pathogens. Journal of Clinical Microbiology. 48: 3353-7. PMID 20592149 DOI: 10.1128/Jcm.00494-10 |
0.356 |
|
| 2010 |
Roll DM, Yang Y, Wildey MJ, Bush K, Lee MD. Inhibition of metallo-beta-lactamases by pyridine monothiocarboxylic acid analogs. The Journal of Antibiotics. 63: 255-7. PMID 20224603 DOI: 10.1038/Ja.2010.20 |
0.496 |
|
| 2010 |
Morrow BJ, He W, Amsler KM, Foleno BD, Macielag MJ, Lynch AS, Bush K. In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone. Antimicrobial Agents and Chemotherapy. 54: 1955-64. PMID 20176911 DOI: 10.1128/AAC.01374-09 |
0.303 |
|
| 2010 |
Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrobial Agents and Chemotherapy. 54: 969-76. PMID 19995920 DOI: 10.1128/Aac.01009-09 |
0.418 |
|
| 2010 |
Shang W, Davies TA, Flamm RK, Bush K. Effects of ceftobiprole and oxacillin on mecA expression in methicillin-resistant Staphylococcus aureus clinical isolates. Antimicrobial Agents and Chemotherapy. 54: 956-9. PMID 19949055 DOI: 10.1128/AAC.01024-09 |
0.307 |
|
| 2009 |
Baum EZ, Crespo-Carbone SM, Morrow BJ, Davies TA, Foleno BD, He W, Queenan AM, Bush K. Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 53: 2785-90. PMID 19433554 DOI: 10.1128/Aac.00018-09 |
0.354 |
|
| 2008 |
Abbanat D, Morrow B, Bush K. New agents in development for the treatment of bacterial infections. Current Opinion in Pharmacology. 8: 582-92. PMID 18761107 DOI: 10.1016/j.coph.2008.08.001 |
0.344 |
|
| 2008 |
Davies TA, Yee YC, Bush K, Sahm D, Evangelista A, Goldschmidt R. Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae. Microbial Drug Resistance (Larchmont, N.Y.). 14: 187-96. PMID 18707553 DOI: 10.1089/Mdr.2008.0805 |
0.311 |
|
| 2008 |
Bush K. Extended-spectrum beta-lactamases in North America, 1987-2006. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 14: 134-43. PMID 18154537 DOI: 10.1111/j.1469-0691.2007.01848.x |
0.305 |
|
| 2008 |
Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy (2001) 45, 4, (1151-1161)) Antimicrobial Agents and Chemotherapy. 52: 809. DOI: 10.1128/Aac.01445-07 |
0.453 |
|
| 2007 |
Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clinical Microbiology Reviews. 20: 440-58, table of con. PMID 17630334 DOI: 10.1128/Cmr.00001-07 |
0.317 |
|
| 2007 |
Davies TA, Page MG, Shang W, Andrew T, Kania M, Bush K. Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 51: 2621-4. PMID 17470659 DOI: 10.1128/AAC.00029-07 |
0.303 |
|
| 2007 |
Bush K, Heep M, Macielag MJ, Noel GJ. Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacy. Expert Opinion On Investigational Drugs. 16: 419-29. PMID 17371191 DOI: 10.1517/13543784.16.4.419 |
0.308 |
|
| 2007 |
Davies T, Sahm D, Flamm R, Bush K. P2026 Activity of ceftobiprole against Pseudomonas aeruginosa clinical isolates from Europe collected in 2005–2006 International Journal of Antimicrobial Agents. 29. DOI: 10.1016/S0924-8579(07)71865-4 |
0.318 |
|
| 2007 |
Davies T, Sahm D, Flamm R, Bush K. P710 Baseline activity of ceftobiprole against methicillin-susceptible and -resistant staphylococcal clinical isolates from Europe collected in 2005–2006 International Journal of Antimicrobial Agents. 29: S172. DOI: 10.1016/S0924-8579(07)70551-4 |
0.397 |
|
| 2006 |
Queenan AM, Shang W, Schreckenberger P, Lolans K, Bush K, Quinn J. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases. Antimicrobial Agents and Chemotherapy. 50: 3485-7. PMID 17005839 DOI: 10.1128/Aac.00363-06 |
0.319 |
|
| 2006 |
Fakioglu E, Queenan AM, Bush K, Jenkins SG, Herold BC. Amp C beta-lactamase-producing Escherichia coli in neonatal meningitis: diagnostic and therapeutic challenge. Journal of Perinatology : Official Journal of the California Perinatal Association. 26: 515-7. PMID 16871223 DOI: 10.1038/Sj.Jp.7211550 |
0.401 |
|
| 2006 |
Davies TA, Shang W, Bush K. Activities of ceftobiprole and other beta-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x. Antimicrobial Agents and Chemotherapy. 50: 2530-2. PMID 16801437 DOI: 10.1128/AAC.00238-06 |
0.325 |
|
| 2006 |
Davies TA, Yee YC, Goldschmidt R, Bush K, Sahm DF, Evangelista A. Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003). The Journal of Antimicrobial Chemotherapy. 57: 437-42. PMID 16431861 DOI: 10.1093/Jac/Dki487 |
0.311 |
|
| 2006 |
Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, Bush K, Hooper DC. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nature Medicine. 12: 83-8. PMID 16369542 DOI: 10.1038/nm1347 |
0.342 |
|
| 2005 |
Frère JM, Galleni M, Bush K, Dideberg O. Is it necessary to change the classification of {beta}-lactamases? The Journal of Antimicrobial Chemotherapy. 55: 1051-3. PMID 15886262 DOI: 10.1093/Jac/Dki155 |
0.344 |
|
| 2005 |
Abbanat D, Webb G, Foleno B, Li Y, Macielag M, Montenegro D, Wira E, Bush K. In vitro activities of novel 2-fluoro-naphthyridine-containing ketolides. Antimicrobial Agents and Chemotherapy. 49: 309-15. PMID 15616310 DOI: 10.1128/AAC.49.1.309-315.2005 |
0.313 |
|
| 2004 |
Bush K, Macielag M, Weidner-Wells M. Taking inventory: antibacterial agents currently at or beyond phase 1. Current Opinion in Microbiology. 7: 466-76. PMID 15451501 DOI: 10.1016/j.mib.2004.08.013 |
0.341 |
|
| 2004 |
Queenan AM, Foleno B, Gownley C, Wira E, Bush K. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. Journal of Clinical Microbiology. 42: 269-75. PMID 14715764 DOI: 10.1128/Jcm.42.1.269-275.2004 |
0.348 |
|
| 2003 |
Yigit H, Queenan AM, Rasheed JK, Biddle JW, Domenech-Sanchez A, Alberti S, Bush K, Tenover FC. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2. Antimicrobial Agents and Chemotherapy. 47: 3881-9. PMID 14638498 DOI: 10.1128/Aac.47.12.3881-3889.2003 |
0.472 |
|
| 2003 |
Jumbe N, Louie A, Leary R, Liu W, Deziel MR, Tam VH, Bachhawat R, Freeman C, Kahn JB, Bush K, Dudley MN, Miller MH, Drusano GL. Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy. The Journal of Clinical Investigation. 112: 275-85. PMID 12865415 DOI: 10.1172/Jci16814 |
0.409 |
|
| 2003 |
Davies TA, Goldschmidt R, Pfleger S, Loeloff M, Bush K, Sahm DF, Evangelista A. Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000). The Journal of Antimicrobial Chemotherapy. 52: 168-75. PMID 12837740 DOI: 10.1093/Jac/Dkg309 |
0.404 |
|
| 2003 |
Materon IC, Queenan AM, Koehler TM, Bush K, Palzkill T. Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis. Antimicrobial Agents and Chemotherapy. 47: 2040-2. PMID 12760895 DOI: 10.1128/Aac.47.6.2040-2042.2003 |
0.348 |
|
| 2003 |
Abbanat D, Macielag M, Bush K. Novel antibacterial agents for the treatment of serious Gram-positive infections. Expert Opinion On Investigational Drugs. 12: 379-99. PMID 12605562 DOI: 10.1517/13543784.12.3.379 |
0.343 |
|
| 2002 |
Bush K. The impact of beta-lactamases on the development of novel antimicrobial agents. Current Opinion in Investigational Drugs (London, England : 2000). 3: 1284-90. PMID 12498001 |
0.335 |
|
| 2002 |
Rasheed JK, Anderson GJ, Queenan AM, Biddle JW, Oliver A, Jacoby GA, Bush K, Tenover FC. TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 46: 2000-3. PMID 12019125 DOI: 10.1128/Aac.46.6.2000-2003.2002 |
0.443 |
|
| 2002 |
Docquier JD, Pantanella F, Giuliani F, Thaller MC, Amicosante G, Galleni M, Frère JM, Bush K, Rossolini GM. CAU-1, a subclass B3 metallo-beta-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosome. Antimicrobial Agents and Chemotherapy. 46: 1823-30. PMID 12019096 DOI: 10.1128/Aac.46.6.1823-1830.2002 |
0.421 |
|
| 2002 |
Davies TA, Evangelista A, Pfleger S, Bush K, Sahm DF, Goldschmidt R. Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000. Antimicrobial Agents and Chemotherapy. 46: 119-24. PMID 11751121 DOI: 10.1128/Aac.46.1.119-124.2002 |
0.318 |
|
| 2002 |
Wong-Beringer A, Hindler J, Loeloff M, Queenan AM, Lee N, Pegues DA, Quinn JP, Bush K. Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 135-46. PMID 11740699 DOI: 10.1086/324742 |
0.399 |
|
| 2001 |
Queenan AM, Jenkins S, Bush K. Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrobial Agents and Chemotherapy. 45: 3189-94. PMID 11600376 DOI: 10.1128/Aac.45.11.3189-3194.2001 |
0.447 |
|
| 2001 |
Baum EZ, Montenegro DA, Licata L, Turchi I, Webb GC, Foleno BD, Bush K. Identification and Characterization of New Inhibitors of the Escherichia coli MurA Enzyme Antimicrobial Agents and Chemotherapy. 45: 3182-3188. PMID 11600375 DOI: 10.1128/Aac.45.11.3182-3188.2001 |
0.426 |
|
| 2001 |
Bush K. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 32: 1085-9. PMID 11264037 DOI: 10.1086/319610 |
0.468 |
|
| 2001 |
Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 45: 1151-61. PMID 11257029 DOI: 10.1128/Aac.45.4.1151-1161.2001 |
0.48 |
|
| 2000 |
Urban C, Mariano N, Rahman N, Queenan AM, Montenegro D, Bush K, Rahal JJ. Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins. Microbial Drug Resistance (Larchmont, N.Y.). 6: 297-303. PMID 11272258 DOI: 10.1089/Mdr.2000.6.297 |
0.47 |
|
| 2000 |
Queenan AM, Torres-Viera C, Gold HS, Carmeli Y, Eliopoulos GM, Moellering RC, Quinn JP, Hindler J, Medeiros AA, Bush K. SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains. Antimicrobial Agents and Chemotherapy. 44: 3035-9. PMID 11036019 DOI: 10.1128/Aac.44.11.3035-3039.2000 |
0.457 |
|
| 2000 |
Grant EB, Guiadeen D, Baum EZ, Foleno BD, Jin H, Montenegro DA, Nelson EA, Bush K, Hlasta DJ. The synthesis and SAR of rhodanines as novel class C beta-lactamase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10: 2179-82. PMID 11012024 DOI: 10.1016/S0960-894X(00)00444-3 |
0.398 |
|
| 2000 |
Fogarty C, Goldschmidt R, Bush K. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. Clinical Infectious Diseases. 31: 613-615. PMID 10987733 DOI: 10.1086/313976 |
0.396 |
|
| 2000 |
Bush K, Macielag M. New approaches in the treatment of bacterial infections Current Opinion in Chemical Biology. 4: 433-439. PMID 10959772 DOI: 10.1016/S1367-5931(00)00106-X |
0.328 |
|
| 1999 |
Yang Y, Testa RT, Bhachech N, Rasmussen BA, Bush K. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties. Antimicrobial Agents and Chemotherapy. 43: 2904-9. PMID 10582880 DOI: 10.1128/Aac.43.12.2904 |
0.438 |
|
| 1999 |
Bush K. beta-Lactamases of increasing clinical importance. Current Pharmaceutical Design. 5: 839-45. PMID 10539991 |
0.323 |
|
| 1999 |
Ahmad M, Urban C, Mariano N, Bradford PA, Calcagni E, Projan SJ, Bush K, Rahal JJ. Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 29: 352-5. PMID 10476741 DOI: 10.1086/520214 |
0.438 |
|
| 1999 |
Hilliard JJ, Goldschmidt RM, Licata L, Baum EZ, Bush K. Multiple Mechanisms of Action for Inhibitors of Histidine Protein Kinases from Bacterial Two-Component Systems Antimicrobial Agents and Chemotherapy. 43: 1693-1699. PMID 10390224 DOI: 10.1128/Aac.43.7.1693 |
0.305 |
|
| 1999 |
Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. Jama. 281: 517-23. PMID 10022107 DOI: 10.1001/Jama.281.6.517 |
0.441 |
|
| 1998 |
Bush K, Miller GH. Bacterial enzymatic resistance: beta-lactamases and aminoglycoside-modifying enzymes. Current Opinion in Microbiology. 1: 509-15. PMID 10066532 DOI: 10.1016/S1369-5274(98)80082-9 |
0.442 |
|
| 1998 |
Bush K. Metallo-beta-lactamases: a class apart. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 27: S48-53. PMID 9710671 |
0.359 |
|
| 1998 |
Yang Y, Bhachech N, Bradford PA, Jett BD, Sahm DF, Bush K. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri. Antimicrobial Agents and Chemotherapy. 42: 1671-6. PMID 9661002 DOI: 10.1128/Aac.42.7.1671 |
0.507 |
|
| 1998 |
Bush K, Mobashery S. How β-Lactamases Have Driven Pharmaceutical Drug Discovery Advances in Experimental Medicine and Biology. 456: 71-98. DOI: 10.1007/978-1-4615-4897-3_5 |
0.483 |
|
| 1997 |
Bush K. Antimicrobial agents. Current Opinion in Chemical Biology. 1: 169-75. PMID 9667849 |
0.337 |
|
| 1997 |
Concha NO, Rasmussen BA, Bush K, Herzberg O. Crystal structures of the cadmium- and mercury-substituted metallo-beta-lactamase from Bacteroides fragilis. Protein Science : a Publication of the Protein Society. 6: 2671-6. PMID 9416622 DOI: 10.1002/Pro.5560061225 |
0.34 |
|
| 1997 |
Bush K. The evolution of beta-lactamases. Ciba Foundation Symposium. 207: 152-63; discussion 1. PMID 9189640 |
0.356 |
|
| 1997 |
Fung-Tomc J, Bush K, Minassian B, Kolek B, Flamm R, Gradelski E, Bonner D. Antibacterial activity of BMS-180680, a new catechol-containing monobactam. Antimicrobial Agents and Chemotherapy. 41: 1010-6. PMID 9145861 DOI: 10.1128/Aac.41.5.1010 |
0.419 |
|
| 1997 |
Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrobial Agents and Chemotherapy. 41: 563-9. PMID 9055993 DOI: 10.1128/Aac.41.3.563 |
0.452 |
|
| 1997 |
Rasmussen BA, Bush K, Tally FP. Antimicrobial resistance in anaerobes. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 24: S110-20. PMID 8994790 |
0.371 |
|
| 1997 |
Lin YI, Bitha P, Li Z, Sakya SM, Strohmeyer TW, Lang SA, Yang Y, Bhachech N, Weiss WJ, Petersen PJ, Jacobus NV, Bush K, Testa RT. Mono and bis double ester prodrugs of novel aminomethyl-THF 1β-methylcarbapenems Bioorganic and Medicinal Chemistry Letters. 7: 1811-1816. DOI: 10.1016/S0960-894X(97)00305-3 |
0.315 |
|
| 1997 |
Lin YI, Bitha P, Sakya SM, Strohmeyer TW, Li Z, Lee VJ, Lang SA, Yang Y, Bhachech N, Weiss WJ, Petersen PJ, Jacobus NV, Bush K, Testa RT, Tally FP. Synthesis and structure-activity relationships of novel THF 1β- methylcarbapenems Bioorganic and Medicinal Chemistry Letters. 7: 1671-1676. DOI: 10.1016/S0960-894X(97)00282-5 |
0.334 |
|
| 1996 |
Yang Y, Bush K. Biochemical characterization of the carbapenem-hydrolyzing beta-lactamase AsbM1 from Aeromonas sobria AER 14M: a member of a novel subgroup of metallo-beta-lactamases. Fems Microbiology Letters. 137: 193-200. PMID 8998985 DOI: 10.1111/J.1574-6968.1996.Tb08105.X |
0.414 |
|
| 1996 |
Rasmussen BA, Bush K, Keeney D, Yang Y, Hare R, O'Gara C, Medeiros AA. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrobial Agents and Chemotherapy. 40: 2080-6. PMID 8878585 DOI: 10.1128/Aac.40.9.2080 |
0.472 |
|
| 1996 |
Concha NO, Rasmussen BA, Bush K, Herzberg O. Crystal structure of the wide-spectrum binuclear zinc beta-lactamase from Bacteroides fragilis. Structure (London, England : 1993). 4: 823-36. PMID 8805566 DOI: 10.1016/S0969-2126(96)00089-5 |
0.422 |
|
| 1996 |
Bush K. Is it important to identify extended-spectrum beta-lactamase-producing isolates? European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 15: 361-4. PMID 8793392 |
0.31 |
|
| 1996 |
Bradford PA, Jacobus NV, Bhachech N, Bush K. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases. Antimicrobial Agents and Chemotherapy. 40: 260-2. PMID 8787920 DOI: 10.1128/Aac.40.1.260 |
0.425 |
|
| 1996 |
Concha NO, Rasmussen BA, Bush K, Herzberg O. Crystal structure of the wide-spectrum binuclear zinc β-lactamase from Bacteroides fragilis Acta Crystallographica Section A. 52: 132-132. DOI: 10.1107/S0108767396093944 |
0.31 |
|
| 1996 |
Hedberg M, Bush K, Bradford PA, Bhachech N, Edlund C, Tunér K, Nord CE. The role of penicillin-binding proteins for β-lactam resistance in a β-lactamase producing bacteroides uniformis strain Anaerobe. 2: 111-115. DOI: 10.1006/Anae.1996.0014 |
0.355 |
|
| 1995 |
Bradford PA, Urban C, Jaiswal A, Mariano N, Rasmussen BA, Projan SJ, Rahal JJ, Bush K. SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrobial Agents and Chemotherapy. 39: 899-905. PMID 7785992 DOI: 10.1128/Aac.39.4.899 |
0.428 |
|
| 1995 |
Yang Y, Bhachech N, Bush K. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases. The Journal of Antimicrobial Chemotherapy. 35: 75-84. PMID 7768785 DOI: 10.1093/Jac/35.1.75 |
0.441 |
|
| 1994 |
Urban C, Meyer KS, Mariano N, Rahal JJ, Flamm R, Rasmussen BA, Bush K. Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 38: 392-5. PMID 8192474 DOI: 10.1128/Aac.38.2.392 |
0.479 |
|
| 1994 |
Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate. Antimicrobial Agents and Chemotherapy. 38: 761-6. PMID 8031043 DOI: 10.1128/Aac.38.4.761 |
0.46 |
|
| 1994 |
Gonzalez Leiza M, Perez-Diaz JC, Ayala J, Casellas JM, Martinez-Beltran J, Bush K, Baquero F. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants. Antimicrobial Agents and Chemotherapy. 38: 2150-7. PMID 7811034 |
0.344 |
|
| 1994 |
Rasmussen BA, Yang Y, Jacobus N, Bush K. Contribution of enzymatic properties, cell permeability, and enzyme expression to microbiological activities of beta-lactams in three Bacteroides fragilis isolates that harbor a metallo-beta-lactamase gene. Antimicrobial Agents and Chemotherapy. 38: 2116-20. PMID 7811029 DOI: 10.1128/Aac.38.9.2116 |
0.477 |
|
| 1994 |
Rasmussen BA, Keeney D, Yang Y, Bush K. Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme. Antimicrobial Agents and Chemotherapy. 38: 2078-85. PMID 7811022 DOI: 10.1128/Aac.38.9.2078 |
0.421 |
|
| 1993 |
Bush K, Macalintal C, Rasmussen BA, Lee VJ, Yang Y. Kinetic interactions of tazobactam with β-lactamases from all major structural classes Antimicrobial Agents and Chemotherapy. 37: 851-858. PMID 8388201 DOI: 10.1128/Aac.37.4.851 |
0.379 |
|
| 1993 |
Rasmussen BA, Bush K, Tally FP. Antimicrobial resistance in Bacteroides. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 16: S390-400. PMID 8324154 DOI: 10.1093/Clinids/16.Supplement_4.S390 |
0.484 |
|
| 1993 |
Rasmussen BA, Bradford PA, Quinn JP, Wiener J, Weinstein RA, Bush K. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences. Antimicrobial Agents and Chemotherapy. 37: 1989-92. PMID 8239618 DOI: 10.1128/Aac.37.9.1989 |
0.442 |
|
| 1992 |
Yang Y, Rasmussen BA, Bush K. Biochemical characterization of the metallo-beta-lactamase CcrA from Bacteroides fragilis TAL3636. Antimicrobial Agents and Chemotherapy. 36: 1155-7. PMID 1510410 DOI: 10.1128/Aac.36.5.1155 |
0.437 |
|
| 1992 |
Naumovski L, Quinn JP, Miyashiro D, Patel M, Bush K, Singer SB, Graves D, Palzkill T, Arvin AM. Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrobial Agents and Chemotherapy. 36: 1991-6. PMID 1416892 DOI: 10.1128/AAC.36.9.1991 |
0.377 |
|
| 1991 |
Sowek JA, Singer SB, Ohringer S, Malley MF, Dougherty TJ, Gougoutas JZ, Bush K. Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. Biochemistry. 30: 3179-88. PMID 1901218 DOI: 10.1021/Bi00227A004 |
0.363 |
|
| 1991 |
Bush K, Flamm RK, Ohringer S, Singer SB, Summerill R, Bonner DP. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase. Antimicrobial Agents and Chemotherapy. 35: 2203-8. PMID 1803992 |
0.345 |
|
| 1989 |
Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 33: 1451-6. PMID 2684007 DOI: 10.1128/Aac.33.9.1451 |
0.497 |
|
| 1989 |
Bush K, Singer SB. Biochemical characteristics of extended broad spectrum beta-lactamases. Infection. 17: 429-33. PMID 2613337 |
0.314 |
|
| 1988 |
Bush K, Smith SA, Tanaka SK, Bonner DP. Inactivation of beta-lactamases from Enterobacter cloacae by monophosphams. The Journal of Antimicrobial Chemotherapy. 22: 801-9. PMID 3266620 DOI: 10.1093/jac/22.6.801 |
0.301 |
|
| 1988 |
Bush K. Beta-lactamase inhibitors from laboratory to clinic. Clinical Microbiology Reviews. 1: 109-23. PMID 3060240 |
0.382 |
|
| 1988 |
Bush K. Recent developments in beta-lactamase research and their implications for the future. Reviews of Infectious Diseases. 10: 681-90. PMID 3055169 |
0.33 |
|
| 1987 |
Bush K, Smith SA, Ohringer S, Tanaka SK, Bonner DP. Improved sensitivity in assays for binding of novel beta-lactam antibiotics to penicillin-binding proteins of Escherichia coli. Antimicrobial Agents and Chemotherapy. 31: 1271-3. PMID 3307621 DOI: 10.1128/Aac.31.8.1271 |
0.33 |
|
| 1987 |
Tanaka SK, Summerill RA, Minassian BF, Bush K, Visnic DA, Bonner DP, Sykes RB. In vitro evaluation of tigemonam, a novel oral monobactam. Antimicrobial Agents and Chemotherapy. 31: 219-25. PMID 3105448 |
0.353 |
|
| 1986 |
Joris B, De Meester F, Galleni M, Masson S, Dusart J, Frère JM, Van Beeumen J, Bush K, Sykes R. Properties of a class C beta-lactamase from Serratia marcescens. The Biochemical Journal. 239: 581-6. PMID 3548700 DOI: 10.1042/Bj2390581 |
0.436 |
|
| 1985 |
Bush K, Tanaka SK, Bonner DP, Sykes RB. Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae. Antimicrobial Agents and Chemotherapy. 27: 555-60. PMID 3873900 DOI: 10.1128/Aac.27.4.555 |
0.465 |
|
| 1984 |
Bush K, Henry PR, Slusarchyk DS. Muraceins--muramyl peptides produced by Nocardia orientalis as angiotensin-converting enzyme inhibitors. I. Taxonomy, fermentation and biological properties. The Journal of Antibiotics. 37: 330-335. PMID 6327590 DOI: 10.7164/Antibiotics.37.330 |
0.301 |
|
| 1984 |
Bush K, Henry PR, Souser-Woehleke M, Trejo WH, Slusarchyk DS. Phenacein--an angiotensin-converting enzyme inhibitor produced by a streptomycete. I. Taxonomy, fermentation and biological properties. The Journal of Antibiotics. 37: 1308-1312. PMID 6096340 DOI: 10.7164/Antibiotics.37.1308 |
0.35 |
|
| 1983 |
Cooper R, Bush K, Principe PA, Trejo WH, Wells JS, Sykes RB. Two new monobactam antibiotics produced by a Flexibacter sp. I. Taxonomy, fermentation, isolation and biological properties. The Journal of Antibiotics. 36: 1252-7. PMID 6643274 DOI: 10.7164/Antibiotics.36.1252 |
0.43 |
|
| 1982 |
Bush K, Freudenberger JS, Sykes RB. Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria. Antimicrobial Agents and Chemotherapy. 22: 414-20. PMID 6982680 |
0.304 |
|
| 1982 |
Sykes RB, Bonner DP, Bush K, Georgopapadakou NH. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrobial Agents and Chemotherapy. 21: 85-92. PMID 6979307 DOI: 10.1128/Aac.21.1.85 |
0.428 |
|
| 1982 |
Wells JS, Trejo WH, Principe PA, Bush K, Georgopapadakou N, Bonner DP, Sykes RB. EM5400, a family of monobactam antibiotics produced by Agrobacterium radiobacter. I. Taxonomy, fermentation and biological properties. The Journal of Antibiotics. 35: 295-9. PMID 6978878 DOI: 10.7164/Antibiotics.35.295 |
0.436 |
|
| 1982 |
Wells JS, Trejo WH, Principe PA, Bush K, Georgopapadakou N, Bonner DP, Sykes RB. SQ 26,180, a novel monobactam. I Taxonomy, fermentation and biological properties. The Journal of Antibiotics. 35: 184-8. PMID 6978877 DOI: 10.7164/Antibiotics.35.184 |
0.478 |
|
| 1981 |
Sykes RB, Cimarusti CM, Bonner DP, Bush K, Floyd DM, Georgopapadakou NH, Koster WM, Liu WC, Parker WL, Principe PA, Rathnum ML, Slusarchyk WA, Trejo WH, Wells JS. Monocyclic beta-lactam antibiotics produced by bacteria. Nature. 291: 489-91. PMID 7015152 DOI: 10.1038/291489a0 |
0.329 |
|
| 1981 |
Sykes RB, Bonner DP, Bush K, Georgopapadakou NH, Wells JS. Monobactams--monocyclic beta-lactam antibiotics produced by bacteria. The Journal of Antimicrobial Chemotherapy. 8: 1-16. PMID 6976959 DOI: 10.1093/JAC/8.SUPPL_E.1 |
0.329 |
|
| 1981 |
SYKES RB, CIMARUSTI CM, BONNER DP, BUSH K, FLOYD DM, GEORGOPAPADAKOU NH, KOSTER WH, LIU WC, PARKER WL, PRINCIPE PA, RATHNUM ML, SLUSARCHYK WA, TREJO WH, WELLS JS. ChemInform Abstract: MONOCYCLIC β-LACTAM ANTIBIOTICS PRODUCED BY BACTERIA Chemischer Informationsdienst. 12. DOI: 10.1002/Chin.198139343 |
0.419 |
|
| 1980 |
Bush K, Bonner DP, Sykes RB. Izumenolide-a novel beta-lactamase inhibitor produced by Micromonospora. II. Biological properties. The Journal of Antibiotics. 33: 1262-9. PMID 6972939 DOI: 10.7164/Antibiotics.33.1262 |
0.438 |
|
| 1973 |
Bush K, Shiner VJ, Mahler HR. Deuterium isotope effects on initial rates of the liver alcohol dehydrogenase reaction. Biochemistry. 12: 4802-5. PMID 4359375 DOI: 10.1021/Bi00747A037 |
0.493 |
|
| 1972 |
Bush KJ, Sweeney BM. The Activity of Ribulose Diphosphate Carboxylase in Extracts of Gonyaulax polyedra in the Day and the Night Phases of the Circadian Rhythm of Photosynthesis. Plant Physiology. 50: 446-51. PMID 16658193 DOI: 10.1104/Pp.50.4.446 |
0.541 |
|
| 1971 |
Bush K, Mahler HR, Shiner VJ. Deuterium effects on binding of reduced coenzyme alcohol dehydrogenase isoenzyme EE. Science (New York, N.Y.). 172: 478-80. PMID 4323799 DOI: 10.1126/Science.172.3982.478 |
0.491 |
|
| Show low-probability matches. |
